DK1002794T3 - 4-(aryl)(aryloxy)methylpiperidinderivater og anvendelse deraf som serotonin og/eller noradrenalingenoptagelsesinhibitorer - Google Patents
4-(aryl)(aryloxy)methylpiperidinderivater og anvendelse deraf som serotonin og/eller noradrenalingenoptagelsesinhibitorerInfo
- Publication number
- DK1002794T3 DK1002794T3 DK99500208T DK99500208T DK1002794T3 DK 1002794 T3 DK1002794 T3 DK 1002794T3 DK 99500208 T DK99500208 T DK 99500208T DK 99500208 T DK99500208 T DK 99500208T DK 1002794 T3 DK1002794 T3 DK 1002794T3
- Authority
- DK
- Denmark
- Prior art keywords
- serotonin
- aryloxy
- aryl
- reuptake inhibitors
- norepinephrine reuptake
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES009802420A ES2157148B1 (es) | 1998-11-18 | 1998-11-18 | Nuevas piperidinas 4-sustituidas. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1002794T3 true DK1002794T3 (da) | 2009-04-14 |
Family
ID=8305832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99500208T DK1002794T3 (da) | 1998-11-18 | 1999-11-10 | 4-(aryl)(aryloxy)methylpiperidinderivater og anvendelse deraf som serotonin og/eller noradrenalingenoptagelsesinhibitorer |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1002794B1 (da) |
| JP (1) | JP4667552B2 (da) |
| KR (1) | KR100646675B1 (da) |
| AR (1) | AR028805A1 (da) |
| AT (1) | ATE422199T1 (da) |
| AU (1) | AU757177B2 (da) |
| BR (1) | BR9905634B1 (da) |
| CA (1) | CA2288533C (da) |
| CY (1) | CY1108955T1 (da) |
| CZ (1) | CZ296053B6 (da) |
| DE (1) | DE69940378D1 (da) |
| DK (1) | DK1002794T3 (da) |
| ES (2) | ES2157148B1 (da) |
| HR (1) | HRP990354B1 (da) |
| HU (1) | HU227558B1 (da) |
| IL (1) | IL132862A0 (da) |
| NO (1) | NO314401B1 (da) |
| PL (1) | PL196329B1 (da) |
| PT (1) | PT1002794E (da) |
| RU (1) | RU2232753C2 (da) |
| TR (1) | TR199902839A2 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003101443A1 (en) * | 2002-05-30 | 2003-12-11 | Head Explorer A/S | The use of milnacipran for the treatment of tension-type headache |
| UA77536C2 (en) * | 2002-07-03 | 2006-12-15 | Lundbeck & Co As H | Secondary aminoaniline piperidines as mch1 antagonists and their use |
| EP1735302B1 (en) | 2004-02-27 | 2010-06-16 | Eli Lilly And Company | 4-amino-piperidine derivatives as monoamine uptake inhibitors |
| CN1968932A (zh) | 2004-06-18 | 2007-05-23 | 惠氏公司 | 制备6－烷基－5－芳基磺酰基－二氢菲啶的方法 |
| EP1854785A1 (en) * | 2006-05-12 | 2007-11-14 | Faes Farma, S.A. | 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions |
| CN101506164A (zh) * | 2006-08-23 | 2009-08-12 | 辉瑞产品公司 | 哌啶衍生物 |
| DK2358674T3 (da) * | 2008-11-14 | 2013-04-08 | Theravance Inc | Fremgangsmåde til fremstilling af 4-[2-(2-fluorphenoxymethyl)phenyl]piperidinforbindelser |
| WO2010120910A1 (en) * | 2009-04-15 | 2010-10-21 | Theravance, Inc. | 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds |
| WO2011147780A1 (en) | 2010-05-24 | 2011-12-01 | Faes Farma, S.A. | Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies |
| EP2390248A1 (en) | 2010-05-24 | 2011-11-30 | Faes Farma, S.A. | Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1203149A (en) * | 1968-06-10 | 1970-08-26 | Ici Ltd | Piperidine derivatives |
| JPH0615529B2 (ja) * | 1985-04-01 | 1994-03-02 | エーザイ株式会社 | 新規ピペリジン誘導体 |
| JPH0840999A (ja) * | 1994-08-04 | 1996-02-13 | Yamanouchi Pharmaceut Co Ltd | フルオロインダン誘導体 |
| CO5150201A1 (es) * | 1998-09-07 | 2002-04-29 | Hoffmann La Roche | Derivados de piperidina |
-
1998
- 1998-11-18 ES ES009802420A patent/ES2157148B1/es not_active Expired - Fee Related
-
1999
- 1999-11-04 CA CA002288533A patent/CA2288533C/en not_active Expired - Fee Related
- 1999-11-08 HU HU9904086A patent/HU227558B1/hu not_active IP Right Cessation
- 1999-11-09 AR ARP990105657A patent/AR028805A1/es active IP Right Grant
- 1999-11-10 DK DK99500208T patent/DK1002794T3/da active
- 1999-11-10 CZ CZ19993995A patent/CZ296053B6/cs not_active IP Right Cessation
- 1999-11-10 PT PT99500208T patent/PT1002794E/pt unknown
- 1999-11-10 IL IL13286299A patent/IL132862A0/xx not_active IP Right Cessation
- 1999-11-10 AT AT99500208T patent/ATE422199T1/de active
- 1999-11-10 EP EP99500208A patent/EP1002794B1/en not_active Expired - Lifetime
- 1999-11-10 ES ES99500208T patent/ES2323742T3/es not_active Expired - Lifetime
- 1999-11-10 DE DE69940378T patent/DE69940378D1/de not_active Expired - Lifetime
- 1999-11-11 AU AU59366/99A patent/AU757177B2/en not_active Ceased
- 1999-11-16 HR HR990354A patent/HRP990354B1/xx not_active IP Right Cessation
- 1999-11-17 RU RU99124412/04A patent/RU2232753C2/ru not_active IP Right Cessation
- 1999-11-17 TR TR1999/02839A patent/TR199902839A2/xx unknown
- 1999-11-17 KR KR1019990051053A patent/KR100646675B1/ko not_active IP Right Cessation
- 1999-11-17 NO NO19995643A patent/NO314401B1/no not_active IP Right Cessation
- 1999-11-17 PL PL336607A patent/PL196329B1/pl not_active IP Right Cessation
- 1999-11-17 BR BRPI9905634-8A patent/BR9905634B1/pt not_active IP Right Cessation
- 1999-11-18 JP JP32888599A patent/JP4667552B2/ja not_active Expired - Fee Related
-
2009
- 2009-04-02 CY CY20091100388T patent/CY1108955T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO972816L (no) | Farmasöytisk blanding omfattende mirtazapin og én eller flere selektive serotonin-gjenopptaks-inhibitorer | |
| NO20013452D0 (no) | Benzoheterocykler og deres anvendelse som MEK-inhibitorer | |
| NO20021659D0 (no) | Biaryleterderivater nyttige som monoamin reopptaksinhibitorer | |
| NO20032830L (no) | Tetrahydropyridinderivater, fremstilling derav og anvendelse som celleproliferasjonsinhibitorer | |
| NO20044095L (no) | 5-fenyltiazolderivater og anvendelse som P13 kinaseinhibitorer | |
| NO20034187D0 (no) | Nye spirotricykliske derivater og anvendelse derav som fosfodiesterase-7 inhibitorer | |
| NO20034307L (no) | Cyklopropylindol-derivater som selektive serotonin- gjenopptaksinhibitorer | |
| NO20002486L (no) | Sykliske aminderivater og deres anvendelse som legemidler | |
| NO20014702L (no) | Diarylderivater og deres anvendelse som medikamenter | |
| NO996491L (no) | 4-brom- eller 4-iod-fenylaminobenzhydroksamsyre-derivater og deres anvendelse som MEK-inhibitorer | |
| NO20012688D0 (no) | Benzamidderivater og anvendelse derav som APOB-100 sekresjonsinhibitorer | |
| DK1454901T3 (da) | Farmaceutiske sammensætninger omfattende tachykininantagonister og en serotoningenoptagelseshæmmer | |
| NO20006029L (no) | Pyrazolinderivater, deres fremstilling og anvendelse som legemidler | |
| NO20014135D0 (no) | Nye sulfonamidforbindelser og deres anvendelse | |
| NO20016406L (no) | Höyselektive reopptaksinhibitorer for norepinefrin | |
| NO20011503D0 (no) | Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, deres fremstilling og anvendelse som anorektiske legemidler | |
| NO20005146D0 (no) | Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter | |
| DK1002794T3 (da) | 4-(aryl)(aryloxy)methylpiperidinderivater og anvendelse deraf som serotonin og/eller noradrenalingenoptagelsesinhibitorer | |
| NO996115D0 (no) | Azetidinylpropylpiperidin-derivater, intermediater og anvendelse som tachykinin-antagonister | |
| DK0602028T3 (da) | Aromatiske sulfonamidderivater, deres anvendelse som enzyminhibitorer og farmaceutiske præparater me d indhold deraf | |
| DK1149094T3 (da) | 4-(aminoalkoxy)-benzofuraner som N-myristoyltransferase-inhibitorer | |
| NO994510D0 (no) | Substituerte isokinolin-derivater og deres anvendelse som antikonvulsanter | |
| NO20022590L (no) | Nye tri-substituerte fenylderivater og analoge | |
| DK1587788T3 (da) | 2,7-substituerede indoler og anvendelsen deraf som 5-HT6-modulatorer | |
| DK0839146T3 (da) | Piperazinderivater og deres anvendelse som 5-HT1A-antagonister |